The Effects of Infliximab on Laminin, NFκB, and Anti-TNF Expression through Its Effect on Ischemic Liver Tissue

Table 2

Antilaminin, anti-NFκB p65, and anti-TNF-α immunopositivity shown in the liver tissues by the method of immunoperoxidase in immunohistochemical staining.

Group	Antilaminin	Anti-NFκB p65	Anti-TNF-α
C	3.00 ± 0.47	4.00 ± 0.42	2.00 ± 0.32
ISC	1.00 ± 0.67	2.00 ± 0.32	4.00 ± 0.48
ISC inf	2.00 ± 0.42	4.00 ± 1.05	3.00 ± 0.47

In the statistical evaluations performed, significant differences were observed between C and ISC groups in terms of antilaminin, anti-NFB p65, and anti-TNF-α immunopositivity according to the Kruskal-Wallis test ().
In the statistical evaluations performed, significant differences were observed between C and ISC inf groups in terms of antilaminin, anti-NFB p65, and anti-TNF-α immunopositivity according to the Kruskal-Wallis test ().
In the statistical evaluations performed, significant differences were observed between ISC and ISC inf groups in terms of antilaminin, anti-NFB p65, and anti-TNF-α immunopositivity according to the Kruskal-Wallis test ().